Somewhat Positive Press Coverage Likely to Impact Esperion Therapeutics (ESPR) Share Price


Press coverage about Esperion Therapeutics has trended somewhat positive recently, according to AlphaOne Sentiment Analysis. The research group, a service of Accern, ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time.



from Biotech News